{"id":"https://openalex.org/W2030161871","doi":"https://doi.org/10.1111/j.1365-2230.1987.tb02501.x","title":"Cimetidine therapy of herpes simplex virus infections in immunocompromised patients","display_name":"Cimetidine therapy of herpes simplex virus infections in immunocompromised patients","publication_year":1987,"publication_date":"1987-09-01","ids":{"openalex":"https://openalex.org/W2030161871","doi":"https://doi.org/10.1111/j.1365-2230.1987.tb02501.x","mag":"2030161871","pmid":"https://pubmed.ncbi.nlm.nih.gov/3446417"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2230.1987.tb02501.x","doi":"https://doi.org/10.1111/j.1365-2230.1987.tb02501.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2230.1987.tb02501.x","pdf_url":null,"source":{"id":"https://openalex.org/S80252431","display_name":"Clinical and Experimental Dermatology","issn_l":"0307-6938","issn":["0307-6938","1365-2230"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I16452829","display_name":"The University of Texas System","ror":"https://ror.org/01gek1696","country_code":"US","type":"education","lineage":["https://openalex.org/I16452829"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"R. KURZROCK","raw_affiliation_strings":["Department of Clinical Immunology and Biological Therapy, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Texas 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology and Biological Therapy, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Texas 77030, USA","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I16452829"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109546883","display_name":"Miklos L Auber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I16452829","display_name":"The University of Texas System","ror":"https://ror.org/01gek1696","country_code":"US","type":"education","lineage":["https://openalex.org/I16452829"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. AUBER","raw_affiliation_strings":["Department of Clinical Immunology and Biological Therapy, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Texas 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology and Biological Therapy, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Texas 77030, USA","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I16452829"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110422116","display_name":"Giora M. Mavligit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I16452829","display_name":"The University of Texas System","ror":"https://ror.org/01gek1696","country_code":"US","type":"education","lineage":["https://openalex.org/I16452829"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G.M. MAVLIGIT","raw_affiliation_strings":["Department of Medical Oncology, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Texas 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Texas 77030, USA","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I16452829"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053481267"],"corresponding_institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I16452829"],"apc_list":{"value":2543,"currency":"GBP","value_usd":3354},"apc_paid":null,"fwci":2.7149,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.89844519,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"12","issue":"5","first_page":"326","last_page":"331"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cimetidine","display_name":"cimetidine","score":1.0},{"id":"https://openalex.org/keywords/herpes-simplex-virus-infection","display_name":"herpes simplex","score":0.9160000085830688},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.9769999980926514},{"id":"https://openalex.org/keywords/mucocutaneous-herpes","display_name":"mucocutaneous herpes","score":0.906000018119812},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.9430000185966492},{"id":"https://openalex.org/keywords/h2-receptor-antagonists","display_name":"H2 receptor antagonists","score":0.6890000104904175},{"id":"https://openalex.org/keywords/herpes-simplex-keratitis","display_name":"herpes simplex keratitis","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C2780719153","wikidata":"https://www.wikidata.org/wiki/Q409492","display_name":"Cimetidine","level":2,"score":0.9476205110549927},{"id":"https://openalex.org/C156662089","wikidata":"https://www.wikidata.org/wiki/Q6931223","display_name":"Mucocutaneous zone","level":3,"score":0.8305490612983704},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8131081461906433},{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.6377052664756775},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4407414495944977},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43207064270973206},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.38063281774520874},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.34989646077156067},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.274060994386673},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.07944506406784058}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002927","descriptor_name":"Cimetidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006561","descriptor_name":"Herpes Simplex","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006561","descriptor_name":"Herpes Simplex","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007108","descriptor_name":"Immune Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2230.1987.tb02501.x","doi":"https://doi.org/10.1111/j.1365-2230.1987.tb02501.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2230.1987.tb02501.x","pdf_url":null,"source":{"id":"https://openalex.org/S80252431","display_name":"Clinical and Experimental Dermatology","issn_l":"0307-6938","issn":["0307-6938","1365-2230"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Dermatology","raw_type":"journal-article"},{"id":"pmid:3446417","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3446417","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental dermatology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1666560847","https://openalex.org/W1819694873","https://openalex.org/W1965413028","https://openalex.org/W1967439259","https://openalex.org/W1986390341","https://openalex.org/W1989523239","https://openalex.org/W1996418205","https://openalex.org/W2011508154","https://openalex.org/W2020200929","https://openalex.org/W2023075511","https://openalex.org/W2026293541","https://openalex.org/W2046763746","https://openalex.org/W2051817506","https://openalex.org/W2057099595","https://openalex.org/W2058226055","https://openalex.org/W2080016157","https://openalex.org/W2081237711","https://openalex.org/W2082263776","https://openalex.org/W2091395732","https://openalex.org/W2094877532","https://openalex.org/W2103711691","https://openalex.org/W2122913682","https://openalex.org/W2130145455","https://openalex.org/W2145502997","https://openalex.org/W2145807988","https://openalex.org/W2316646354","https://openalex.org/W2337413481","https://openalex.org/W2405533973","https://openalex.org/W2442455700","https://openalex.org/W2466491102","https://openalex.org/W4235029647","https://openalex.org/W4238094256","https://openalex.org/W4249435505","https://openalex.org/W4285719527","https://openalex.org/W4301868472","https://openalex.org/W4376490599"],"related_works":["https://openalex.org/W2412331039","https://openalex.org/W2277114491","https://openalex.org/W1646298074","https://openalex.org/W2011508154","https://openalex.org/W2051817506","https://openalex.org/W2466200639","https://openalex.org/W7117485545","https://openalex.org/W1967439259","https://openalex.org/W2063371642","https://openalex.org/W2072081560"],"abstract_inverted_index":{"Five":[0],"severely":[1],"immunocompromised":[2],"patients":[3,69],"with":[4,16,70],"progressive":[5],"mucocutaneous":[6],"manifestations":[7],"of":[8,44],"culture-proven":[9],"herpes":[10,71],"simplex":[11],"virus":[12,72],"infection":[13],"were":[14],"treated":[15],"cimetidine\u20141200":[17],"mg":[18],"per":[19],"day":[20],"by":[21,26,38],"mouth":[22],"(four":[23],"patients)":[24],"or":[25],"i.v.":[27],"infusion":[28],"(one":[29],"patient).":[30],"Treatment":[31],"resulted":[32],"in":[33,68],"rapid":[34],"improvement":[35],"as":[36],"evidenced":[37],"decreased":[39],"local":[40],"pain":[41],"and":[42],"crusting":[43],"lesions":[45],"within":[46,53],"24\u201348":[47],"h.":[48],"Complete":[49],"resolution":[50],"was":[51],"observed":[52],"3\u201313":[54],"days.":[55],"These":[56],"encouraging,":[57],"albeit":[58],"preliminary,":[59],"findings":[60],"suggest":[61],"that":[62],"cimetidine":[63],"warrants":[64],"further,":[65],"large-scale":[66],"trials":[67],"infections.":[73]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}